2025-01-01 2025-12-31 2025-12-31 false 15373509 JSA & EA Crabtree & SON Livestock Ltd 01500Mixed farming iso4217:GBP xbrli:pure 153735092025-01-01 153735092025-12-31 153735092025-01-01 2025-12-31 15373509bus:SmallEntities2025-01-01 2025-12-31 15373509bus:AuditExempt-NoAccountantsReport2025-01-01 2025-12-31 15373509bus:FullAccounts2025-01-01 2025-12-31 15373509core:WithinOneYear2025-12-31 15373509core:AfterOneYear2025-12-31 15373509core:WithinOneYear2025-01-01 2025-12-31 15373509core:AfterOneYear2025-01-01 2025-12-31 15373509core:CurrentFinancialInstruments2025-12-31 15373509core:Non-currentFinancialInstruments2025-12-31 15373509core:CurrentFinancialInstruments2025-01-01 2025-12-31 15373509core:Non-currentFinancialInstruments2025-01-01 2025-12-31 15373509core:LandBuildings2025-01-01 2025-12-31 15373509core:FurnitureFittings2025-01-01 2025-12-31 15373509core:OfficeEquipment2025-01-01 2025-12-31 15373509core:Vehicles2025-01-01 2025-12-31 15373509core:PlantMachinery2025-01-01 2025-12-31 15373509core:OtherPropertyPlantEquipment2025-01-01 2025-12-31 15373509core:LandBuildings2025-12-31 15373509core:PlantMachinery2025-12-31 15373509core:Vehicles2025-12-31 15373509core:FurnitureFittings2025-12-31 15373509core:OfficeEquipment2025-12-31 15373509core:OtherPropertyPlantEquipment2025-12-31 15373509core:Right-of-useAssets2025-01-01 2025-12-31 15373509core:Right-of-useAssets2025-12-31 15373509core:Goodwill2025-01-01 2025-12-31 15373509core:PatentsTrademarksLicencesConcessionsSimilar2025-01-01 2025-12-31 15373509core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-01 2025-12-31 15373509core:OtherResidualIntangibleAssets2025-01-01 2025-12-31 15373509core:Goodwill2025-12-31 15373509core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-12-31 15373509core:PatentsTrademarksLicencesConcessionsSimilar2025-12-31 15373509core:OtherResidualIntangibleAssets2025-12-31 15373509dpl:CostSales2025-01-01 2025-12-31 15373509dpl:AdministrativeExpenses2025-01-01 2025-12-31 15373509dpl:DistributionCosts2025-01-01 2025-12-3115373509core:ShareCapital2025-12-31 15373509core:SharePremium2025-12-31 15373509core:RevaluationReserve2025-12-31 15373509core:OtherReservesSubtotal2025-12-31 15373509core:ShareCapitalPreferenceShares2025-12-31 15373509core:CapitalRedemptionReserve2025-12-31 15373509core:OtherCapitalReserve2025-12-31 15373509core:RetainedEarningsAccumulatedLosses2025-12-3115373509core:ShareCapital2025-01-01 2025-12-31 15373509core:SharePremium2025-01-01 2025-12-31 15373509core:RevaluationReserve2025-01-01 2025-12-31 15373509core:OtherReservesSubtotal2025-01-01 2025-12-31 15373509core:RetainedEarningsAccumulatedLosses2025-01-01 2025-12-311537350912025-01-01 2025-12-31 1537350922025-01-01 2025-12-3115373509core:ShareCapital12025-01-01 2025-12-31 15373509core:ShareCapital22025-01-01 2025-12-3115373509core:SharePremium12025-01-01 2025-12-31 15373509core:SharePremium22025-01-01 2025-12-3115373509core:RevaluationReserve12025-01-01 2025-12-31 15373509core:RevaluationReserve22025-01-01 2025-12-3115373509core:RetainedEarningsAccumulatedLosses12025-01-01 2025-12-31 15373509core:RetainedEarningsAccumulatedLosses22025-01-01 2025-12-311537350912025-01-01 2025-12-3115373509core:Non-currentFinancialInstrumentscore:CostValuation2025-01-01 15373509core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-31 15373509core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-31 15373509core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-31 15373509core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2025-12-31 15373509core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3115373509core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-01-01 15373509core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-31 15373509core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-31 15373509core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-31 15373509core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2025-12-31 15373509core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-31 15373509core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-12-3115373509core:Non-currentFinancialInstruments2025-12-31 15373509core:Non-currentFinancialInstruments2024-12-31153735092023-12-28 153735092024-12-31 153735092023-12-28 2024-12-31 15373509core:WithinOneYear2024-12-31 15373509core:AfterOneYear2024-12-31 15373509core:CurrentFinancialInstruments2024-12-31 15373509core:Non-currentFinancialInstruments2024-12-31 15373509core:LandBuildings2024-12-31 15373509core:PlantMachinery2024-12-31 15373509core:Vehicles2024-12-31 15373509core:FurnitureFittings2024-12-31 15373509core:OfficeEquipment2024-12-31 15373509core:OtherPropertyPlantEquipment2024-12-31 15373509core:Right-of-useAssets2024-12-31 15373509core:Goodwill2024-12-31 15373509core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-12-31 15373509core:PatentsTrademarksLicencesConcessionsSimilar2024-12-31 15373509core:OtherResidualIntangibleAssets2024-12-31 15373509dpl:AdministrativeExpenses2023-12-28 2024-12-3115373509core:ShareCapital2024-12-31 15373509core:SharePremium2024-12-31 15373509core:RevaluationReserve2024-12-31 15373509core:OtherReservesSubtotal2024-12-31 15373509core:ShareCapitalPreferenceShares2024-12-31 15373509core:CapitalRedemptionReserve2024-12-31 15373509core:OtherCapitalReserve2024-12-31 15373509core:RetainedEarningsAccumulatedLosses2024-12-3115373509core:RetainedEarningsAccumulatedLosses2023-12-28 15373509core:ShareCapital2023-12-28 15373509core:SharePremium2023-12-28 15373509core:RevaluationReserve2023-12-28 15373509core:ShareCapital2023-12-28 2024-12-31 15373509core:SharePremium2023-12-28 2024-12-31 15373509core:RevaluationReserve2023-12-28 2024-12-31 15373509core:OtherReservesSubtotal2023-12-28 2024-12-31 15373509core:RetainedEarningsAccumulatedLosses2023-12-28 2024-12-311537350912023-12-28 2024-12-31 1537350922023-12-28 2024-12-3115373509core:ShareCapital12023-12-28 2024-12-31 15373509core:ShareCapital22023-12-28 2024-12-3115373509core:SharePremium12023-12-28 2024-12-31 15373509core:SharePremium22023-12-28 2024-12-3115373509core:RevaluationReserve12023-12-28 2024-12-31 15373509core:RevaluationReserve22023-12-28 2024-12-3115373509core:RetainedEarningsAccumulatedLosses12023-12-28 2024-12-31 15373509core:RetainedEarningsAccumulatedLosses22023-12-28 2024-12-3115373509bus:Director12025-01-01 2025-12-3115373509bus:Director22025-01-01 2025-12-3115373509bus:Director32025-01-01 2025-12-3115373509bus:PrivateLimitedCompanyLtd2025-01-01 2025-12-31
JSA & EA Crabtree & SON Livestock Ltd
Unaudited Financial Statements
for the year ended 31 December 2025
Company registration number 15373509
(England and Wales)

Company Information

For the year ended 31 December 2025
Directors Crabtree, Elizabeth Ann
Crabtree, John Steven Andrew
Crabtree, Simon Jonathan

Registered office The Four Columns
Broughton Hall Business Park
Skipton
BD23 3AE

Registered number 15373509

Accountant H & M Ltd
The Four Columns
Broughton Hall Business Park
Skipton
BD23 3AE

Statement of Financial Position

As at 31 December 2025
Notes
2025
2024
£
£
£
£
Current assets
Stocks
336,773
195,674
Debtors
4
2,295
10,276
Cash at bank and in hand
52,292
79,543
391,360
285,493
Creditors
Amounts falling due within one year
5
(265,033)
(253,592)
(265,033)
(253,592)
Net current assets (liabilities)
126,327
31,901
Total assets less current liabilities
126,327
31,901
Net assets (liabilities)
126,327
31,901
Capital and reserves
Called up share capital
3
3
Profit and loss account
126,324
31,898
Total equity
126,327
31,901

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 14 July 2026 and are signed on its behalf by:

Crabtree, John Steven Andrew
Crabtree, John Steven Andrew
Director

Company registration number 15373509

Notes to the Financial Statements

For the year ended 31 December 2025

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.


Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.



2.3. Deferred tax

Deferred taxation is provided on the liability method to take account of timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes.

 

Tax deferred or accelerated is accounted for in respect of all material timing differences, in particular accelerated capital allowances and revaluation gains on investment properties. All deferred tax is charged/(credited) to the Income Statement.

 

2.4. Stocks and work in progress

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

2.5. Financial Instruments

The following assets and liabilities are classified as financial instruments - trade debtors, trade creditors, bank loans and directors' loans.

 

Bank loans are initially measured at the present value of future payments, discounted at a market rate of interest, and subsequently at amortised cost using the effective interest method.

 

Directors' loans (being repayable on demand), trade debtors and trade creditors are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.

 

Financial assets that are measured at amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Income Statement.

3. Employees

The average number of employees during the year was 3 (2024: 3).

4. Debtors

2025
2024
£
£
Other debtors
2,295
10,011
Prepayments and accrued income
-
265
Total due within one year
2,295
10,276
Total due after one year
-
-
Total
2,295
10,276

5. Creditors due within one year

2025
2024
£
£
Trade creditors
36,657
21,335
Other creditors
178,084
203,426
Directors loan account
20,349
20,349
Taxation and social security
28,943
7,482
Accruals and deferred income
1,000
1,000
Total
265,033
253,592